Mark Heinen
CIK 1888531 · Chief Financial Officer · last filed 2025-05-09
Mark Heinen is a Chief Financial Officer who has filed 11 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for SOAR, was dated May 9, 2025. Across all open-market trades the lifetime net is +$141.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $39.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$39.1K
3
11
$141.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SOAR | Chief Financial Officer | 192,963 | $0.20 | $39.1K | $0 | 1 | 2025-05-09 |
| Volato Group, Inc. (SOAR.WS) Delisted | Chief Financial Officer | 147,963 | $0.01 | $1.0K | $6.8K | 2 | 2024-06-11 |
| Better Therapeutics, Inc. (BTTX) Delisted | Chief Financial Officer | 142,003 | $0.04 | $6.3K | $135.1K | 8 | 2023-04-21 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-09 | SOAR | Grant (A) | +45,000 | $0 | EDGAR |
| 2024-06-11 | Volato Group, Inc. (SOAR.WS) Delisted | Grant (A) | +139,463 | $0 | EDGAR |
| 2024-06-10 | Volato Group, Inc. (SOAR.WS) Delisted | Buy (P) | +8,500 | $6.8K | EDGAR |
| 2023-04-21 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | +54,000 | $0 | EDGAR |
| 2022-12-02 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | +15,723 | $19.5K | EDGAR |
| 2022-09-14 | Better Therapeutics, Inc. (BTTX) Delisted | Buy (P) | +50,000 | $97.0K | EDGAR |
| 2022-06-28 | Better Therapeutics, Inc. (BTTX) Delisted | Buy (P) | +2,280 | $4.0K | EDGAR |
| 2022-06-10 | Better Therapeutics, Inc. (BTTX) Delisted | Buy (P) | +5,000 | $7.8K | EDGAR |
| 2022-04-04 | Better Therapeutics, Inc. (BTTX) Delisted | Mixed | +5,000 | $9.9K | EDGAR |
| 2021-12-15 | Better Therapeutics, Inc. (BTTX) Delisted | Buy (P) | +3,333 | $16.4K | EDGAR |